SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008940
Filing Date
2018-11-08
Accepted
2018-11-08 12:22:46
Documents
59
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ecyt-20180930x10q.htm 10-Q 1716690
2 EX-31.1 ecyt-20180930ex311aafcf6.htm EX-31.1 19943
3 EX-31.2 ecyt-20180930ex31252ee1f.htm EX-31.2 18026
4 EX-32.1 ecyt-20180930ex321a8ef5a.htm EX-32.1 15435
  Complete submission text file 0001558370-18-008940.txt   6397146

Data Files

Seq Description Document Type Size
5 EX-101.INS ecyt-20180930.xml EX-101.INS 1353287
6 EX-101.SCH ecyt-20180930.xsd EX-101.SCH 44267
7 EX-101.CAL ecyt-20180930_cal.xml EX-101.CAL 34383
8 EX-101.DEF ecyt-20180930_def.xml EX-101.DEF 219511
9 EX-101.LAB ecyt-20180930_lab.xml EX-101.LAB 384698
10 EX-101.PRE ecyt-20180930_pre.xml EX-101.PRE 340139
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35050 | Film No.: 181168937
SIC: 2834 Pharmaceutical Preparations